Sakamoto T [32] proposed that BRAF V600E was tested positive by immunostaining (anti-BRAF V600E rabbit monoclonal antibody clones) and NGS in both adenocarcinoma and LCNEC part. This evidence concerns the gene BRAF and large cell neuroendocrine carcinoma.